Does LEUPROLIDE Cause Injection site haemorrhage? 623 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 623 reports of Injection site haemorrhage have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.9% of all adverse event reports for LEUPROLIDE.
623
Reports of Injection site haemorrhage with LEUPROLIDE
0.9%
of all LEUPROLIDE reports
23
Deaths
34
Hospitalizations
How Dangerous Is Injection site haemorrhage From LEUPROLIDE?
Of the 623 reports, 23 (3.7%) resulted in death, 34 (5.5%) required hospitalization.
Is Injection site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 623 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Injection site haemorrhage?
ADALIMUMAB (11,715)
EXENATIDE (5,527)
ETANERCEPT (4,674)
TIRZEPATIDE (4,389)
EVOLOCUMAB (3,720)
DULAGLUTIDE (3,028)
TERIPARATIDE (2,330)
GALCANEZUMAB-GNLM (1,415)
DUPILUMAB (1,401)
HUMIRA (1,304)
Which LEUPROLIDE Alternatives Have Lower Injection site haemorrhage Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM